COPENHAGEN, Denmark, Jan. 5, 2026 /PRNewswire/ — Curasight A/S (“Curasight” or “the Company” – (CPH: CURAS) a clinical-stage theranostic company focused on diagnosingCOPENHAGEN, Denmark, Jan. 5, 2026 /PRNewswire/ — Curasight A/S (“Curasight” or “the Company” – (CPH: CURAS) a clinical-stage theranostic company focused on diagnosing

Curasight to hold Meetings in San Francisco During J.P. Morgan Healthcare Conference Week

COPENHAGEN, Denmark, Jan. 5, 2026 /PRNewswire/ — Curasight A/S (“Curasight” or “the Company” – (CPH: CURAS) a clinical-stage theranostic company focused on diagnosing and treating certain types of cancers, announced that CEO Ulrich Krasilnikoff and CMO prof. Andreas Kjær will be in San Francisco during the 44th J.P. Morgan Healthcare Conference being held January 12-15, 2026.

During the week, Curasight management will hold meetings with investors and other industry stakeholders. The meetings will include updates on the Company’s clinical progress, including the recent initiation of a Phase 1 trial with uTREAT® in aggressive brain cancer, and the ongoing Phase 2 trial of uTRACE® in prostate cancer conducted in partnership with Curium Inc.

About the uPAR theranostic platform

Curasight’s uPAR theranostic platform combines two key technologies – uTRACE and uTREAT both targeting the uPAR receptor. uTRACE is designed to deliver sensitive imaging for diagnosis, while uTREAT offers a targeted radiopharmaceutical solution. Together, they form an integrated approach to improving the diagnosis and treatment of cancers that express uPAR. Curasight’s ambition is to develop both uTRACE and uTREAT to improve diagnosis and treatment of uPAR-expressing cancers.

For more information regarding Curasight, please contact:
Ulrich Krasilnikoff, CEO
Phone: +45 22 83 01 60
E-mail: [email protected]

www.curasight.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/curasight/r/curasight-to-hold-meetings-in-san-francisco-during-j-p–morgan-healthcare-conference-week,c4288616

The following files are available for download:

https://mb.cision.com/Main/19744/4288616/3862590.pdf

Curasight Press release – JPM 26

Cision View original content:https://www.prnewswire.com/news-releases/curasight-to-hold-meetings-in-san-francisco-during-jp-morgan-healthcare-conference-week-302652512.html

SOURCE Curasight

Market Opportunity
PoP Planet Logo
PoP Planet Price(P)
$0.01235
$0.01235$0.01235
+0.48%
USD
PoP Planet (P) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Shibarium May No Longer Turbocharge Shiba Inu Price Rally, Here’s Reason

Shibarium May No Longer Turbocharge Shiba Inu Price Rally, Here’s Reason

The post Shibarium May No Longer Turbocharge Shiba Inu Price Rally, Here’s Reason appeared on BitcoinEthereumNews.com. Shibarium, the layer-2 blockchain of the Shiba Inu (SHIB) ecosystem, is battling to stay active. Shibarium has slipped from hitting transaction milestones to struggling to record any transactions on its platform, a development that could severely impact SHIB. Shibarium transactions crash from millions to near zero As per Shibariumscan data, the total daily transactions on Shibarium as of Sept. 16 stood at 11,600. This volume of transactions reflects how low the transaction count has dropped for the L2, whose daily average ranged between 3.5 million and 4 million last month. However, in the last week of August, daily transaction volume on Shibarium lost momentum, slipping from 1.3 million to 9,590 as of Aug. 28. This pattern has lingered for much of September, with the highest peak so far being on Sept. 5, when it posted 1.26 million transactions. The low user engagement has greatly affected the transaction count in recent days. In addition, the security breach over the weekend by malicious attackers on Shibarium has probably worsened issues. Although developer Kaal Dhairya reassured the community that the attack to steal millions of BONE tokens was successfully prevented, users’ confidence appears shaken. This has also impacted the price outlook for Shiba Inu, the ecosystem’s native token. Following reports of the malicious attack on Shibarium, SHIB dipped immediately into the red zone. Unlike on previous occasions where investors accumulated on the dip, market participants did not flock to Shiba Inu. Shiba Inu price struggles, can burn mechanism help? With the current near-zero crash in transaction volume for Shibarium, SHIB’s price cannot depend on it to support a rally. It might take a while to rebuild user confidence and for transactions to pick up again. In the meantime, Shiba Inu might have to rely on other means to boost prices from its low levels. This…
Share
BitcoinEthereumNews2025/09/18 07:57
Shiba Inu to Encrypt All Transactions by Q2 2026 as Privacy Era Takes Hold

Shiba Inu to Encrypt All Transactions by Q2 2026 as Privacy Era Takes Hold

On the Shibarium roadmap, SHIB, BONE, LEASH and TREAT will be FHE shielded in Q2 2026,  as confirmed by Zama CEO Rand Hindi. The plan includes confidential balances
Share
Crypto News Flash2026/01/30 22:34
Tokenized Real-World Assets (RWA): Why Institutions Are Moving On-Chain in 2026

Tokenized Real-World Assets (RWA): Why Institutions Are Moving On-Chain in 2026

Finance is changing shape. Not overnight, not loudly, but steadily. One of the clearest signals of that shift in 2026 is the growing institutional move toward tokenized
Share
Blockchainmagazine2026/01/30 22:10